RT Journal Article
SR Electronic
T1 Vitamin D: Current Guidelines and Future Outlook
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 1145
OP 1151
VO 38
IS 2
A1 STEFAN PILZ
A1 CHRISTIAN TRUMMER
A1 MARLENE PANDIS
A1 VERENA SCHWETZ
A1 FELIX ABERER
A1 MARTIN GRÜBLER
A1 NICOLAS VERHEYEN
A1 ANDREAS TOMASCHITZ
A1 WINFRIED MÄRZ
YR 2018
UL http://ar.iiarjournals.org/content/38/2/1145.abstract
AB Vitamin D is of public health interest because its deficiency is common and is associated with musculoskeletal diseases, as well as extraskeletal diseases, such as cancer, cardiovascular diseases, and infections. Several health authorities have reviewed the existing literature and published nutritional vitamin D guidelines for the general population. There was a wide consensus that serum 25-hydroxyvitamin D [25(OH)D] concentration should be used to assess vitamin D status and intake, and that musculoskeletal, and not extraskeletal, effects of vitamin D should be the basis for nutritional vitamin D guidelines. Recommended target levels for 25(OH)D range from 25 to 50 nmol/l (10 to 20 ng/ml), corresponding to a vitamin D intake of 400 to 800 International Units (10 to 20 μg) per day. It is of concern that significant sections of the general population do not meet these recommended vitamin D levels. This definitely requires action from a public health perspective.